The Strategic Management of Research and Development by Nodoushani, Omid & Nodoushani, Patricia
3Journal of Comparative International Management ©2002 Management Futures
2002, Vol. 5, No. 1, 3-15 Printed in Canada
The Strategic Management of 
Research and Development 
by
Omid Nodoushani
Southern Connecticut State University, USA
And
Patricia Nodoushani
University of Hartford  
Research and Development has changed forever.  At one time, laboratories
were filled with PhDs who were hired by corporations to develop new technol-
ogy and address a very general, perceived future need. Today, all that has
changed. R&D has become a strategic, competitive tool for corporations to
gain market, as well as market share, through new products or innovative
processes.  In this paper we discuss the R&D challenges that corporations are
facing for developing a competitive strategy in an age of global capitalism.
INTRODUCTION: OPENING NEW MARKETS
When one thinks of how a company develops opportunities for a new
market/product, one of the first ideas which comes to mind, is Research and
Development.  Research and Development (R&D) is very often thought of as
hi-tech, futuristic thinking that results in innovation and strategic advantage.
There is a broad spectrum of ideas and concepts that are contained within the
term “Research and Development” and the various steps that are taken in the
process of converting an idea into a product or process.  
These processes are costly and the decision to support any of them com-
petes with investment opportunities that often have more immediate benefits.
The biggest debate within industrial organizations, universities and government
is deciding how much capital should be devoted to R&D.  Different industries
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invest differently in R&D, but the common theme remains the same: How long
will it take to recover our investment? 
While some observers lament that the US technological position has
declined rapidly in key industrial sectors since 1979 (Schwartz, 1992), the chal-
lenge of incorporating R&D into the corporation’s competitive strategy has
become greater than ever.  Current research has highlighted a crucial link
between business competitive strategy and technological innovations
(Knoedler, 1990), yet there is growing discontent between scientists and man-
agement in corporate America (Gaines, 1994).
Managing R&D is an area of business performance directly linked to the
different ways of generating financial resources to support R&D projects.  This
includes funding by private corporations, joint ventures, arrangements between
industries and universities, government funding to universities and industries,
and venture capitalists. 
The manner in which companies handle the process of R&D depends
largely on the type and size of the company.  The majority of companies fall
into the following two classifications and have been found to have an important
influence on the approaches that are followed (Compton, 1997:448). 
In order for companies to stay successful and competitive in today’s glob-
al marketplace, each must determine the right formula for their business struc-
ture.  Even companies of the same size in the same industry have varying
approaches for managing R&D.
Large National/ High-Tech 
Multinational Mature Companies Companies
Large companies experience difficulty May or may not be 
in being entrepreneurial entrepreneurial
Multi-disciplinary teams may be difficult Multi-disciplinary teams are frequent 
Technology often focuses on development Technology derived internally 
and continuous improvement or externally
Small Mature Companies Entrepreneurial Companies
Entrepreneurial approach is uncommon Emphasizes entrepreneurial approach
Small size fosters multidisciplinary teams Multi-disciplinary teams are common
Technology often derived externally Technology often derived internally.
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CORPORATE FUNDED R & D
One of the most common methods of funding  R&D is for a private cor-
poration to use existing financial and technical resources.   This can be consid-
ered high-risk but hi-tech companies that show repeated successes using R&D
for new products usually win the support of Wall Street investors when these
new ideas are publicly released.  
Even in tough economic times, many companies look to R&D as a pos-
sible competitive advantage.  A hi-tech recession may be impacting Taiwan
Semiconductor Manufacturing Co. (TSM), but these are nonetheless busy times
for Shang-Yi Chiang, TSMC’s senior vice-president for research and develop-
ment.  The slowdown in chip production has made it possible for his 460 engi-
neers to accelerate their research on next-generation chip making techniques.
“During a recession, people have much more energy to spend on R&D,”
according to Shang-Yi Chiang.  While the rest of TSMC is under a hiring
freeze, Chiang is expanding his staff by 10% (BWO, 2001). 
This is a very effective way to utilize human resources during periods of
economic slow-down without losing a competitive advantage by downsizing
employees.  However, this approach is not always possible for all companies.
Battelle Labs, which normally is contracted to provide technical analysis and
R&D support to companies, is changing how it does business in the competi-
tive R&D environment.  CEO Douglas E. Olesen has also redirected the insti-
tute to “cash-in” on its intellectual property.  Where in the past Battelle may
have received $50,000 for a contract to help a company launch a $50-million-
a-year product, Battelle may now develop the product itself in one of the small
companies it has spawned.  
An outstanding example is Battelle Pulmonary Therapeutics, a for-profit
venture that is conducting clinical trials on inhalation chemotherapy treatment
for lung cancer patients. A team of 300 physicists, engineers, toxicologists, and
other specialists helped develop this pioneering device (Bylinsky, 2000).
COLLABORATIVE  PARTNERSHIP
Interest in corporate R&D ventures is by no means dead (Drucker, 1991).
In a few exceptional cases, such as Xerox Corporation’s Palo Alto Research
Center (PARC) and within the major chemical companies such as DuPont,
basic research continues.  Ever since the cost-cutting excesses of the mid-
1980’s triggered a bloodbath at the big research labs, corporate R&D has been
shifting more and more from the “R” part of the equation toward the “D.” Even
the U. S. Department of Defense was forced to scale back in R&D spending.
This trend has continued even though overall R&D spending has
rebounded.  According to the Industrial Research Institute, an organization of
FORTUNE 1,000 research directors, corporate R&D budgets increased from
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$97 billion in 1994 to $166 billion in 2001.  However, the innovative content
of corporate research has been greatly diminished in favor of work that supports
short-term goals, such as improvement of existing products.  Over the past fif-
teen years, some companies simply closed their R&D labs while others atom-
ized central labs by assigning the research to wholly owned divisions.  
Companies with R&D labs are trying to enrich their research activities in
other ways.  Many are collaborating with national labs, private research insti-
tutions and universities.  MIT used to get two-thirds of its outside support from
government and one-third from industry.  Now the proportions have been
reversed.  While five years ago MIT received $565 million in research funds
from corporations for sponsored research on campus, last year the figure
reached a record $73 million.
Unfortunately, purchasing research conducted by others is not a panacea.
“Buying from the outside is risky unless you have enough in-house expertise,”
says Arthur Chester, president of the Hughes Research Laboratory in Malibu,
Calif.  “And technology developed elsewhere usually needs adaptation and
additional development before you can use it in your business.”  In-house
expertise is also becoming harder to acquire.  According to Karl Koster, direc-
tor of corporate relations at MIT, “Big companies used to have their pick of
MIT students.  Now they are having a hell of a time recruiting them” (Bylinsky,
2000).
New players are stepping forward to create innovative technologies out-
side of corporate labs.   One of the most exciting technologies of the new mil-
lennium is currently moving closer to the mass market.  This technology is fuel
cells, almost universally seen as an energy-conserving, low-pollution way to
power millions of tomorrow’s motor vehicles.  Standing in the way is econom-
ics, which can be overcome only by chipping away at manufacturing costs and
building plants large enough to realize economies of scale.  Though Daimler
Chrysler and others still plan to sell the first fuel-cell cars in California in 2004,
mass production by the auto industry isn’t likely to begin any earlier than 2008.  
The big carmakers have collectively committed more than $1 billion to
this dream.  Meanwhile, the emergence of fuel-cell products for other uses,
though produced in far smaller volumes than those foreseen for motor vehicles,
is significantly advancing the manufacturing know-how that the automakers
will need:
• Production engineers at Ballard Power Systems in Vancouver, working
closely with Daimler Chrysler and Ford, are revving up to produce fuel
cells that will be the heart of a small portable electricity-generating
device.  Sunbeam Corporation’s Coleman Powermate unit plans to have
it in stores for this year’s Christmas selling season.
• Plug Power in Latham, N.Y., which has a distribution agreement with
General Electric, has just begun shipping the first fuel-cell generating
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units designed to make a home or small business largely independent of
the electric-power grid.
• International Fuel Cell in South Windsor, Conn., which already makes
large 200-kilowatt fuel-cell generators for commercial use, will roll out a
new version in 2003 which will cost two-thirds less as the result of design
and manufacturing improvements (Brown, 2001).
The prime benefit of collaborative partnerships is the sharing of the
extraordinary high cost of developing an alternative energy source.  Few peo-
ple realize how important venture capital has become for innovation in the
United States. Although universities, national labs, and corporations continue
to develop important new technologies, it is the role of the venture capitalist
that has become the most crucial.  
Last year total venture funding reached $100 billion and accounted for
55% of the money spent in the U.S. on R&D, according to the National Science
Foundation and Venture Economics.  By comparison, venture funding made up
only 4% of the overall research spending in 1990—a period of slow economic
growth.  What’s more, venture firms are extremely effective at bargaining inno-
vative ideas to market.  According to Josh Lerner, a professor at Harvard
Business School, venture financing leads to three to five times more innova-
tions than corporate or university funding where too many of the research labs
are more academic than commercial (Green, 2001).
According to a recent report (Green, 2001), the following table demon-
strates how R&D monies have been distributed over different industries. 
INTELLECTUAL PROPERTY
Intellectual property now accounts for a major part of American eco-
nomic growth and interest by investors in R&D has grown (Schacht, 2000).  To
promote further economic growth in cooperative R&D, the U. S. government
A Few Tech Sectors Get Most of the Funding…
Industry Number of Companies Amount invested in
Funded in 1st Quarter 2001 Billions
Computer Software 207 $2.06
Internet E-Commerce/ 264 $2.03
Content/Services
Internet Communications 71 $1.31
Fibre Optics 37 $0.95
Data Communications 55 $0.73
Data: Venture Economics
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has enacted legislation (Bayh-Dole) which allows intellectual property that has
government sponsorship to be retained by the contractor performing the R&D.
(Tassey, 1995).   The intent of this legislation is to protect a company’s R&D
from competition. 
The World Intellectual Property Organization (WIPO) defines subcate-
gories under intellectual property as follows: “Literary, artistic and scientific
works; performances of performing artists, phonographs and broadcasts; indus-
trial designs; trademarks; service marks and commercial names and designa-
tions; and all other rights resulting from intellectual activity in the industrial,
scientific, literary and artistic fields” (WIPO, 1967).
From an R&D perspective, the definition of intellectual property would
focus on the literary (e.g. manuals & software) and scientific works.  A compa-
ny’s intellectual property may include trademarks and commercial names, but
majority of the R&D intellectual property falls under literary and scientific
works. 
Intellectual property rights are defined as legally protected rights that
enable owners of intellectual property to exert monopoly control of their intel-
lectual property, usually for commercial gain.  These rights prevent others from
exploiting intellectual property for a fixed period of time or, in some cases,
indefinitely.  Intellectual property rights include patents, copyrights, registered
and unregistered design rights, trademarks, and know-how.
The patent system (a  “monopoly of monopolies” (Noble, 1977)), gives
exclusive rights to the owner that excludes members of the public from mak-
ing, using or selling the item subject to the patent.   In order to be patentable,
an invention must pass four tests:
1. The invention must fall into one of the five “statutory classes” of
things that are patentable:
a. Processes, 
b. Machines,
c. Manufacturers (that is, objects made by humans or machines),
composition of matter, and
2. The invention must be “useful”. One aspect of the “utility” test is
that the invention cannot be a mere theoretical phenomenon.
3. The invention must be “novel”, that is, it must be something that no
one did before.
4. The invention must be “unobvious” to “a person having ordinary
skill in the art to which said subject matter pertains”. This require-
ment is the one on which many patentability disputes hinge.
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Excluded from patent protection are mathematical algorithms, methods
of treatment of human or animal body by surgery or therapy, or methods of
diagnosis. Terms for patents vary from 14 to 20 years depending on the type of
patent and, under exceptional circumstances when pharmaceutical products are
involved, an extension of 5 years may be granted.  Patents are published and
give the full details of the invention.
Copyright is a category of intellectual property for the protection of
literary or artistic work and computer software. Copyrights can be registered
(U.S. Copyright Office) or unregistered and fall under the general protection of
copyright laws.  In the United States, unregistered works are protected under
copyright laws when the original work is fixed in a tangible medium.  In short,
the first time an unregistered work is saved to a media storage device the work
is copyrighted.  The term for copyright protection of a literary work is 50 years
beyond the author’s death, 50 years from the end of the calendar year in which
the software was created, and 25 years for typographical arrangements.
Register Design Rights are composed mainly of aesthetic objects
where the appearance is unique.  Registered Design Rights have a term of 5
years and are renewable on application for up to four further periods of 5 years
each.  From the perspective of R&D Intellectual property, Register Design
Rights do not apply.  Unregistered Design Rights are engineering components
of architectural drawings.  Unregistered Design Rights normally expire 15
years from the end of the calendar year in which the design drawing was first
recorded or the design object made.   R&D intellectual property for unregis-
tered Design Rights would be limited to engineering components. 
TradeMarks are product brand names or company logos and can be
maintained indefinitely.  Under U.S. trademark law, the C-in-a-circle symbol
(©) may only be used in connection with a mark if that mark is a federally reg-
istered trademark. Federally registered means that the trademark owner has not
only filed a trademark registration application with the U.S. Patent &
Trademark Office but has been granted a registration from that office. From the
perspective of R&D Intellectual property, trademarks do not apply.   Know-how
consists of trade secrets or background techniques, and can persist indefinitely.
Know-how protection is achieved by keeping the information secret but can be
licensed like other items of intellectual property.
ECONOMIC VALUE OF R&D
When dealing with the economic value of R&D, many researchers
want to know where the company will be in 15 or 20 years.  To address this
issue, the common procedure is to investigate the established goals of the com-
pany’s R&D department and then the support that the company gives to those
goals.  Technology goals are usually looked at first.  A technology goal is
defined as how a company seeks to fill a need, a niche or simply invent.  The
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second, and more prolific goal, is the constant drive for profit.   This search for
profit is at the crux of all improvements in product features, manufacturing
techniques, raw material and processes, and has changed entire industries by
transforming a company into a top competitor in its industry.   
The December 2001 issue of IndustryWeek.com, lists 29 R&D develop-
ments to watch in the next few years (IW, 2002).  Of the 29 projects listed, 24
involve cutting-edge new technology.   The company that sponsors and sup-
ports this type of R&D is the company that will become the next household
name.  Pfizer, Bell Labs and DuPont all support new technology as a routine
part of their business.   Many of the products we use and interact with each day
were once, and may still be considered, new technology. 
This type of R&D function opens up new markets.  It also contains the
highest risk because very often, simultaneous development is underway by at
least two independent entities. There is still lingering doubt as to the true inven-
tor of the telephone and the light bulb. Often, inventors of projects that have
taken tremendous resources to develop have been beaten to the patent office by
mere hours, negating the entire project and the potential for and financial
return. 
Although new technology holds the limelight of the press and public,
there is a much greater portion of R&D that is in the background. This is the
R&D of manufacturing and product improvement.  There is often a combina-
tion of technologies applied to improve a process or solve a problem.  For
instance, Millennium Pharmaceuticals in Cambridge Massachusetts, has been
able to incorporate a new technology platform for conduction experiments
(Thomke, 2001).  Another example is BMW, which has utilized crash test sim-
ulations with computers in order to predict accurate, and sometimes surprising,
results at a fraction of the cost of building prototypes. 
Conducting R&D is not just a goal of many companies; it can also
become a force that changes the goals of companies. The R&D work at BMW
to develop the simulated crash tests enabled BMW to reorganize and rethink its
old methods of design development and information transfer.  Such a rethink-
ing, and subsequent adoption of new design methods, essentially slashed devel-
opment costs and boosted innovation.
Despite these attributes, researchers often debate whether R&D can be a
strategic asset to a company.  Obviously, it depends on the company and how
the R&D function is managed.  There is often a large gap between management
expectations and the output of the R&D function.  There may also exist orga-
nizational conflicts, unrealistic expectations and a basic inability to understand
the unique problems of the R&D function.   
In so doing, the effectiveness and productiveness of the R&D function
depends on the company’s needs measured in terms of both innovation and
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manufacturing reliability.  In other words, a well-managed R&D function will
balance its goals between new technology and high value products and the
appropriate location of such a balance depends upon the company’s strategic
goals.
THE SOCIAL VALUE OF R&D
One stakeholder of any business is the general public.  As such, it is pru-
dent that companies spend R&D dollars not only on making better products, but
also by improving the quality of life with those products.  Often it becomes a
requirement to produce a product that is in line with current social issues and
political thinking (Blackburn, Green, and Liff, 1982).  In the pursuit of appeal-
ing to such issues, better products are often made and new markets opened up. 
For example, many of our packaging containers today are made from
biodegradable and recycled products.  This is due not only to a social trend
towards a “greener” earth, but also as a result of seeking more cost-effective
packaging.  An entire industry has sprung up since the early 1970’s just to deal
with recycling what was once thrown away.   Fisheries Research and
Development Corporation (FRDC), a statutory Australian corporation formed
in 1991, is responsible for the planning, funding and managing of R&D pro-
grams.  It also facilitates the dissemination, adoption and commercialization of
the results of R&D.  FRDC’s stakeholders include the fishing industry, the gov-
ernments of the commonwealth, and the people of Australia.
The National Aeronautics and Space Administration (NASA) is a huge
R&D group and contributes hundreds of new products, materials and applica-
tions each year to the government and the general public.  The NASA 1999
commercial invention of the year is a thermoplastic material.  It was developed
at NASA’s Langley Research Center in Hampton, Virginia.  The thermoplastic
offers protection from UV radiation as a coating for art and outdoor statues, can
be used as an additive to lipstick and paint, and has electronic manufacturing
uses as well due to it’s temperature resistant properties.
The benefits of R&D to our society are numerous, however; society has
different ways for defining what is beneficial and what is not.  Human cloning
is technically a reality today but there exists no general social acceptance of the
technology for such a purpose.  The atomic bomb, while leading to many high-
ly beneficial innovations and technology, is considered the pinnacle of man’s
evil to man.  Simply because something can be made and developed does not
mean it should. The first question every shareholder of R&D should ask is not
“Can we?” but rather “Should we?”
Stakeholders of any R&D group are the sponsors, the local and national
governments, the general public and the financial organizations now and in the
future.  R&D must exist for all stakeholders of the organization, not just for
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purposes of the bottom-line.  Meeting those challenges requires careful organ-
ization, planning and management.
DOWNSIZING AND CORPORATE R&D
Downsizing, rightsizing, reengineering, and  “lean and mean” — all refer
to reducing the workforce to match the mission of the corporation.  In times of
high economic growth and low unemployment, corporations tend to keep
employees for a number of reasons, even when they are out of touch with the
technical needs of the corporation or business unit (Crease, 1991; Budiansky,
1993). 
Generally, the level of over-employment remains until an outside force
pushes the corporation to critical mass.  The outside force can come from com-
petition redefining a like product offering.  This new definition might include a
low cost product without services, which may be amenable to some customers.
The lack of a competitive edge in the area of new technology might drive a
competitor to accept that weakness and turn it around with an across-the-board
price cut.  This move may help sales and improve   competition.  At worst, the
company with the innovative R&D group will have to live with lower profit
margins by matching the lower prices (assuming that the overhead of its R&D
effort is larger than the competition), or look for other ways to differentiate
itself in the market.  If it fails to sell its value to the customer, it may decide to
downsize to quickly cut costs. 
During the past two years, Proctor and Gamble has laid off over 17,000
people due to the competitive nature of the home care and personal care busi-
ness, “where several companies are saddled with less-than-desirable earnings
and are under pressure to control costs” (Watkins, 2001).  Automotive compa-
nies are requiring their vendors to come up with new technological solutions to
meet the market needs in the future.  At the same time, some of these same
automotive original equipment manufacturers (OEM) have cut back on their
technical groups to save costs. In these situations, the end customer is telling all
its vendors to do more with less (and for less!). In fiercely competitive markets,
there always seems to be a company that will fill the end customer’s needs.
There are many negative impacts to downsizing, however.  With some
companies, the first step to downsizing is a voluntary program.  Separation
packages for senior employees may make later, mandatory lay-offs less painful.
One issue that can develop, is that during a voluntary separation program, some
of the most valuable employees leave the corporation.  There is a real interrup-
tion in “organizational memory” as a result.  
The key resources for some of the survivors are lost.  Many R&D func-
tions over the years generate a network of coworkers as sounding boards or his-
torical resources before proceeding with new ideas.  The indirect use of the
most talented, senior technical employees have always been there, but are not
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generally acknowledged.  In some cases, it is necessary for the corporation to
hire back these employees as consultants for a short time, generating another
mixed message to the survivors.
Another result of downsizing the R&D function of a corporation is the
perceived lack of value that employees feel for themselves and their work.
Displaced workers and survivors alike feel that the corporation views them
only as indirect costs, overhead, or a  “bottom-line” savings potential, but not
as people contributing, to the best of their ability, to the corporation’s success.
The secrecy that exists prior to a downsizing announcement and the suddenness
of the announcement, further add to the survivor’s insecurity and lack of worth.
In many cases, this causes a potential loss of trust of the individual employee
to their direct manager and to the corporation itself (Mishra, 1998).  Morale
generally drops significantly as employees feel that they have lost control of
their own destinies within the corporation. Invariably when a corporation
downsizes, the workload doesn’t immediately lower.  The survivors are usual-
ly left to cover for their displaced coworkers, sometimes taking over for more
than one. For the motivated professional, this can take “the wind out of their
sails” and burnout is not uncommon. 
Private industry is not the only area affected by R&D downsizing. In
March of 1999, NASA documented its Workforce Restructuring Plan.   At
NASA budgets are controlled by the Senate and the House of Representatives
and subject to political whims.  NASA approaches this with an aggressive rede-
finition of itself to survive in the 21st century.  It was NASA’s vision to come
out of restructuring with a more focused workforce, releasing responsibilities
that were best delivered by other vendors.  NASA chose to lose some of the
control it previously had, and return the agency back to its roots as a “premier”
R&D organization.  
NASA recognized early that an organization could not do the same work
with less people, but that it would need to focus “internal efforts on technolo-
gy development, transferring operational activities to commercial contractors
as appropriate”.  By defining a clean separation of what it would, and more
importantly would not do, it is able to redeploy its efforts to fit its new organi-
zational goals.  Of course, the rigid approach that NASA took was not always
easy. NASA wanted to use attrition and buyouts (early retirement, etc) to man-
age the reduction guidelines in lieu of major lay-offs.  A hiring freeze prevent-
ed some managers from filling positions that had specific skill requirements.
This is a concern in any downsizing action.  If the survivors cannot meet the
requirements of their new responsibilities, managers must be aware of these
limitations, and provide additional training or education.
All in all, downsizing R&D in a corporation or government facility has
long-term ramifications.  Managers and employees are both affected, and the
relationship between them can be strained for long periods of time.  Such bot-
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tom-line savings are momentary and superficial while the effects on the work-
force can last for years.  People are emotional creatures, and the fears and
uncertainty that downsizing create are difficult to overturn. The more corpora-
tions are able to “over-communicate” during times of downsizing, the better the
effects are on the survivors.  And, corporations must always be mindful to their
missions.  If broad R&D efforts are not in line with these goals (in a particular
department or business unit), a smaller more manageable redeployment of peo-
ple to other opportunities within the corporation will result in the least disrup-
tive working environment for the people involved in R&D.           
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